Last $1.30 USD
Change Today -0.15 / -10.34%
Volume 6.4K
IFIT On Other Exchanges
As of 5:20 PM 09/2/14 All times are local (Market data is delayed by at least 15 minutes).

isatori inc (IFIT) Snapshot

Previous Close
Day High
Day Low
52 Week High
09/30/13 - $3.27
52 Week Low
08/1/14 - $1.20
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ISATORI INC (IFIT)

Related News

No related news articles were found.

isatori inc (IFIT) Related Businessweek News

No Related Businessweek News Found

isatori inc (IFIT) Details

iSatori, Inc., a consumer products company, is engaged in the research, design, development, manufacture, marketing, sale, and distribution of various nutritional and dietary supplement products worldwide. It offers sports nutritionals; energy and sports drinks and shots; meal replacement proteins, protein-based products related to weight loss, and nutritional bars; and weight loss products. The company sells its products through online marketing, Fortune 500 retailers, and retail stores. iSatori, Inc. was founded in 2001 and is headquartered in Golden, Colorado.

23 Employees
Last Reported Date: 08/11/14
Founded in 2001

isatori inc (IFIT) Top Compensated Officers

Founder, Owner, Chairman, Chief Executive Off...
Total Annual Compensation: $225.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $126.0K
Compensation as of Fiscal Year 2013.

isatori inc (IFIT) Key Developments

iSatori, Inc. Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

iSatori, Inc. reported unaudited earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company has posted total revenue of $2,918,367 against $2,279,928 a year ago. Income from operations was $213,951 against $36,397 a year ago. Income before income tax was $399,481 against loss before income tax of $61,126 a year ago. Net income was $336,099 or $0.02 diluted per share against $133,222 or $0.01 diluted per share a year ago. For the six months, the company has posted $6,179,634 against $4,536,295 a year ago. Income from operations was $568,212 against loss from operations of $44,317 a year ago. Income before income tax was $672,337 against loss before income tax of $314,112 a year ago. Net income was $336,099 or $0.05 diluted per share against $129,898 or $0.01 diluted per share a year ago. Cash flow provided by operations was a positive $825,829 for the six months ended June 30, 2014, compared to cash used of $163,475 for the six months ended June 30, 2013.

iSatori, Inc. Launches Six Flavors, Under Category-Defining Bio-Gro(TM) Bio-Active Peptides Product Brand

iSatori, Inc. announced the launch of six flavors, under the category-defining Bio-Gro(TM) bio-active peptides product brand. New flavors include Vanilla Ice Cream, Chocolate Ice Cream, Cookies N' Cream, Strawberry Banana Swirl, Orange Creamsicle, and the favorite flavor of Founder and Chief Executive Officer, Stephen Adelé, Snickerdoodle. Bio-Gro(TM) bio-active peptides compete within the sports nutrition segment of dietary nutritional supplements, which, according to the most recent Nutrition Business Journal reports, has seen double digit growth over the past two years, and all nutritional supplements market sales are now valued at $35 billion. As a brand new category called 'bio-active peptides', within sports nutrition, Bio-Gro(TM) has set the stage for continued growing interest from retailers and consumers alike who are interested in improving muscular performance. Customers can now find Bio-Gro in eight different countries outside the U.S., including Canada (GNC), India, Australia, Italy, Greece, Iceland, UAE, and New Zealand; and domestically.

iSatori, Inc. Releases the Results of a Brand-New Clinical Study on its Energy Pill, Energize

iSatori, Inc. released the results of a brand-new clinical study on its popular energy pill, Energize, titled 'Pharmacokinetics of caffeine administered in a time-release [Energize] versus regular tablet form'. The study, which was a double-blind, placebo-controlled, randomized clinical trial (the gold standard of studies), was performed by the Institute of Exercise Physiology and Wellness at the University of Central Florida (UCF) in Orlando and presented at this year's annual ISSN Conference in Clearwater, Florida on June 21, 2014. The clinical trial confirms the company's claims for extended energy when Energize is consumed from a single dose. Energize was compared in a double-blind, placebo-controlled, cross-over study to an equivalent dose of caffeine (194 mg) and a placebo. Blood was taken when the products were initially ingested and every subsequent hour for an eight-hour period. The researchers confirmed that while the common caffeine quickly reached its peak after three hours, with Energize, the caffeine didn't reach its peak until six full hours after ingestion and remained present for up to the eight hours. The UCF researchers concluded that absorption following Energize ingestion was both slower and more sustained, which could prolong the effects of caffeine and limit the common caffeine 'crash'.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IFIT:US $1.30 USD -0.15

IFIT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $42.23 USD -0.01
USANA Health Sciences Inc $71.05 USD -1.98
Vitamin Shoppe Inc $39.50 USD +0.31
View Industry Companies

Industry Analysis


Industry Average

Valuation IFIT Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.5x
Price/Book 5.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ISATORI INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at